Ligand validation:4HYX

C14: TETRADECANE

C14 is a Ligand Of Interest in 4HYX designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HYX_C14_B_305	7%	81%	0.278	0.735	0.25	0.57	-	-	1	0	100%	1
5H2I_C14_A_612	5%	71%	0.199	0.613	0.31	0.81	-	-	0	0	100%	1
5B6W_C14_A_612	4%	71%	0.21	0.6	0.31	0.81	-	-	0	0	100%	1
5B6X_C14_A_612	4%	71%	0.226	0.606	0.31	0.81	-	-	0	0	100%	1
5B6Y_C14_A_612	3%	71%	0.214	0.561	0.31	0.81	-	-	0	0	100%	1
5H2H_C14_A_612	3%	71%	0.227	0.571	0.31	0.81	-	-	0	0	100%	1
7PZF_C14_B_404	50%	87%	0.113	0.914	0.26	0.44	-	-	0	0	71%	0.7143
8RNR_C14_B_305	4%	95%	0.259	0.629	0.19	0.2	-	-	2	0	100%	0.9

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.